PEPCID COMPLETE
LOE Approachingfamotidine, calcium carbonate, magnesium hydroxide chewable tablet
NDAORALTABLET, CHEWABLE
Approved
Oct 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
PEPCID COMPLETE (famotidine, calcium carbonate, magnesium hydroxide chewable tablet) by Kenvue Brands is histamine h2 receptor antagonists [moa]. First approved in 2000.
Drug data last refreshed 13h ago · AI intelligence enriched 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PEPCID COMPLETE is a fixed-dose combination chewable tablet combining famotidine (H2-receptor antagonist), calcium carbonate, and magnesium hydroxide for rapid relief of heartburn and acid indigestion. It works by reducing stomach acid production via histamine H2-receptor antagonism while providing immediate alkalizing relief. This OTC product targets consumers seeking fast, multi-mechanism symptom relief in the gastroesophageal reflux disease (GERD) and dyspepsia market.
LOE Approaching
As an OTC product approaching loss of exclusivity, PEPCID COMPLETE operates in a mature, competitive market with moderate competitive pressure (30/100), suggesting stable but limited expansion opportunities for brand and field teams.
Mechanism of Action
Histamine H2 Receptor Antagonists
Pharmacologic Class:
Histamine-2 Receptor Antagonist
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
PEPCID COMPLETE offers limited career momentum due to its LOE-approaching status and zero linked job openings; roles are primarily defensive and focused on maintaining market share rather than innovation or launch activities. Professionals joining this asset should expect stable but non-growth career trajectory in a mature OTC segment.
Brand Manager
Worked on PEPCID COMPLETE at Kenvue Brands? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.